艾力斯(688578.SH)：创新药伏美替尼、戈来雷塞纳入新版国家医保目录

智通财经12-07 16:02

智通财经APP讯，艾力斯(688578.SH)发布公告，公司创新药品甲磺酸伏美替尼片(商品名“艾弗沙®️”，以下简称“伏美替尼”)和枸橼酸戈来雷塞片(商品名“艾瑞凯®️”，以下简称“戈来雷塞”)均被纳入《国家基本医疗保险、生育保险和工伤保险药品目录(2025年)》(以下简称“国家医保目录”)。其中，伏美替尼一线及二线治疗适应症经医保谈判后继续纳入国家医保目录;戈来雷塞二线治疗适应症通过医保谈判方式首次被纳入国家医保目录。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2589879337?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-12-07 16:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2589879337","market":"sh","top_or_hot":-1,"title":"艾力斯(688578.SH)：创新药伏美替尼、戈来雷塞纳入新版国家医保目录","media":"智通财经","content":"<html><body><p>智通财经APP讯，<a href=\"https://laohu8.com/S/688578\">艾力斯</a>(688578.SH)发布公告，公司创新药品甲磺酸伏美替尼片(商品名“艾弗沙®️”，以下简称“伏美替尼”)和枸橼酸戈来雷塞片(商品名“艾瑞凯®️”，以下简称“戈来雷塞”)均被纳入《国家基本医疗保险、生育保险和工伤保险药品目录(2025年)》(以下简称“国家医保目录”)。其中，伏美替尼一线及二线治疗适应症经医保谈判后继续纳入国家医保目录;戈来雷塞二线治疗适应症通过医保谈判方式首次被纳入国家医保目录。</p></body></html>","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>艾力斯(688578.SH)：创新药伏美替尼、戈来雷塞纳入新版国家医保目录</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n艾力斯(688578.SH)：创新药伏美替尼、戈来雷塞纳入新版国家医保目录\n</h2>\n\n<h4 class=\"meta\">\n\n<p class=\"head\">\n<strong class=\"h-name small\">智通财经</strong><span class=\"h-time small\">2025-12-07 16:02</span>\n</p>\n\n</h4>\n\n</header>\n<article>\n<html><body><p>智通财经APP讯，<a href=\"https://laohu8.com/S/688578\">艾力斯</a>(688578.SH)发布公告，公司创新药品甲磺酸伏美替尼片(商品名“艾弗沙®️”，以下简称“伏美替尼”)和枸橼酸戈来雷塞片(商品名“艾瑞凯®️”，以下简称“戈来雷塞”)均被纳入《国家基本医疗保险、生育保险和工伤保险药品目录(2025年)》(以下简称“国家医保目录”)。其中，伏美替尼一线及二线治疗适应症经医保谈判后继续纳入国家医保目录;戈来雷塞二线治疗适应症通过医保谈判方式首次被纳入国家医保目录。</p></body></html>\n\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"http://www.zhitongcaijing.com/content/detail/1378477.html\">智通财经</a> </p>\n\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n</div>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"688578","symbol_name":"艾力斯","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1378477.html","article_id":"2589879337","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2589879337","pubTimestamp":1765094576,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，艾力斯(688578.SH)发布公告，公司创新药品甲磺酸伏美替尼片(商品名“艾弗沙®️”，以下简称“伏美替尼”)和枸橼酸戈来雷塞片(商品名“艾瑞凯®️”，以下简称“戈来雷塞”)均被纳入《国家基本医疗保险、生育保险和工伤保险药品目录(2025年)》(以下简称“国家医保目录”)。其中，伏美替尼一线及二线治疗适应症经医保谈判后继续纳入国家医保目录;戈来雷塞二线治疗适应症通过医保谈判方式首次被纳入国家医保目录。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159992":"创新药","688578":"艾力斯","06978":"永泰生物-B","BK1161":"生物科技","BK0239":"医药制造","BK1574":"生物医药B类股"},"translate_title":"Ellis (688578. SH): Innovative drugs fumetinib and golelexe are included in the new version of the National Medical Insurance Catalog","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159992":1.5,"688578":1.5,"06978":1.5},"content_text":"智通财经APP讯，艾力斯(688578.SH)发布公告，公司创新药品甲磺酸伏美替尼片(商品名“艾弗沙®️”，以下简称“伏美替尼”)和枸橼酸戈来雷塞片(商品名“艾瑞凯®️”，以下简称“戈来雷塞”)均被纳入《国家基本医疗保险、生育保险和工伤保险药品目录(2025年)》(以下简称“国家医保目录”)。其中，伏美替尼一线及二线治疗适应症经医保谈判后继续纳入国家医保目录;戈来雷塞二线治疗适应症通过医保谈判方式首次被纳入国家医保目录。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease,policyRegulatory","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.10","shortVersion":"4.35.10","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2589879337","isCrawlerRequest":true}